The Role of Neurovascular Compromise, Autoimmune Antibodies and Neuronal Calcium Sensor Proteins During the Onset and Progression of Alzheimer's Disease - Linking the Retina with the Brain
2016
- 8Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage8
- Downloads6
- Abstract Views2
Thesis / Dissertation Description
Alzheimer's disease (AD), the main cause of dementia, is a progressive and irreversible neurodegenerative disease. The pathological hallmarks of the disease include bloodbrain barrier (BBB) breach, neurofibrillary tang les and amyloid plaques. Also, emerging evidence has raised the possibility that instead of a secondary consequence, the neuroinflammation contributes to the development and early progression of AD. However, the mechanism underlying the blood-neural barrier (BNB), chronic inflammation and neuronal degenerative diseases (NDDs) remain to be elucidated.To explore the role of the chronic inflammation in NDDs and delineate the early steps of these diseases, in vivo drug-induced and transgenic mouse models together with an ex vivo organotypic culture model were generated. Analyses helped establish a temporal sequence of events in both types of models. A chronic compromise of BBB in S100B knockout (S100BKO) mice was reported for the first time. Coincident with the increase in Immunoglobulin G (IgG) - bound cells, autoantibodies targeting brain proteins were detected in the serum. These events were concurrent with neuronal compromise, astrocytic activation and abnormal microglia. Based on the results, a key role for S100B in maintaining the functional integrity of the BNB is proposed.As a window to the brain, retina was also examined under similar experimental settings. Parallel pathological changes were perceived indicating that the retina, specifically the photoreceptors and Muller cells, was a reliable detector for the associated changes in the brain.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know